Draycott SCR
ABOUT DRAYCOTT SCR
Draycott SCR is a Lisbon multi-asset Sociedade de Capital de Risco founded in 2019, running buyout and real estate strategies alongside a SIFIDE-eligible Growth Fund I that provides growth capital to established Portuguese companies across sectors. Draycott's operating-company portfolio includes Verescence, Purever, Pradecon, TTM Group, Nextbitt, and Science4you, while its growth and venture exposure spans names such as Coverflex, Kencko Foods, Sword Health, Rows, Tucuvi, and Punto Health. On the real estate side it holds projects including Belém Vista, Estoril Two . Four, Atlantic Pines, Alta de Lisboa, and the Amoreiras Vista and Amoreiras Residence developments. The firm is led by CEO and Founding Partner João Coelho Borges, with Francisco Guimarães Neto as Partner and António Gellweiler and Hugo Gonçalves Pereira as Non-Executive Partners. By combining buyouts, real estate, and a SIFIDE-eligible growth vehicle, Draycott SCR spans several asset classes. Details are available at draycott.pt.
INVESTMENT THESIS
Growth capital for established Portuguese companies across sectors.
INVESTMENT DETAILS
TEAM
FREQUENTLY ASKED QUESTIONS
What stage does Draycott SCR invest at?
Draycott SCR invests at Growth stage.
What sectors does Draycott SCR invest in?
Draycott SCR focuses on Multi-Sector.
Where is Draycott SCR based?
Draycott SCR is a VC (SCR) based in Lisbon, Portugal, founded in 2019.
Who are the partners at Draycott SCR?
Key people at Draycott SCR include João Coelho Borges (CEO & Founding Partner), António Gellweiler (Non-Executive Partner), Hugo Gonçalves Pereira (Non-Executive Partner), Francisco Guimarães Neto (Partner).
What companies has Draycott SCR invested in?
Draycott SCR's portfolio includes Verescence, Purever, Pradecon, TTM Group, Greenview, Viriato Funerárias, Claro, Exus Management Partners, among others.
How do I contact or pitch Draycott SCR?
You can reach Draycott SCR via their website (draycott.pt). You can also submit your startup through Portugal VC's pitch tool to be forwarded to matching investors.